Navigation Links
Lilly Highlights Transformation Strategy for Wall Street, Reviews Robust Pipeline and Sets 2009 Financial Guidance
Date:12/11/2008

risk-sharing collaborations with companies in both India and China.

Tom Bumol, Ph.D., vice president of biotech discovery research, explained how the company's biotechnology strategy is transforming the Lilly pipeline. "We see more and more that biotech is a key to sustaining pharmaceutical innovation for the future, and Lilly has more than eight decades of experience with biologicals. Today, Lilly is the fifth largest biopharmaceutical company based on biotherapeutic sales, and we are making the necessary investments to strengthen our leadership position. Over the past decade, we have built a new integrated biotechnology infrastructure, from discovery through development, and including delivery devices and manufacturing."

Highlighting Lilly's growing biotech prowess, Dr. Paul remarked, "With the addition of the ImClone cancer antibodies, currently 40 percent of Lilly's clinical stage pipeline and 50 percent of Lilly's late-stage pipeline are comprised of biotechnology-based molecules. Through the ImClone acquisition, we have simultaneously accelerated our emergence as both a biotech and cancer powerhouse, with a pipeline that we believe will provide a continuous flow of high value medicines."

Key late-stage and select mid-stage compounds in each of the company's core therapeutic areas were reviewed by Drs. Paul and Bumol.

Select Pipeline Developments

-- Prasugrel - The company continues to invest heavily in the ongoing development of prasugrel. Prasugrel, which Lilly is developing with its partner Daiichi Sankyo, continues to be under review with the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMEA) for treatment of acute coronary syndrome (ACS) in patients undergoing percutaneous coronary intervention (PCI). Lilly remains in active dialogue with both regulatory agencies. In addition, prasugrel is also being studied in the TRILOGY trial in medically-ma
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
2. Lilly Declares Fourth-Quarter Dividend
3. Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
4. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
5. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
6. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
7. Lilly Announces Termination of AIR Insulin Program
8. HistoRx and Lilly Extend, Expand AQUA(R) Analysis Partnership
9. Pelikan Technologies and Lilly Form Alliance to Promote Diabetes Education
10. Lilly Reports Solid First-Quarter Results
11. Lilly CEO Praises Massachusetts Leadership in Biotech, Urges Policy Prescriptions to Help Ensure States Investment Generates Dividends and Jobs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... /PRNewswire/ -- Capitalizing on the continued ... an active venture capital market, leaders from BioCrossroads, ... Fund, Indiana University, Purdue University, the University of ... Suisse today announced the establishment of the INext ... funds. ,, Organized through BioCrossroads, Indiana,s initiative to ...
(Date:12/16/2009)... Dec. 16 Sequenom, Inc. (Nasdaq: ... Kenneth Buechler and Mr. David Pendarvis to its ... http://www.newscom.com/cgi-bin/prnh/20040415/SQNMLOGO ) ,, Kenneth F. Buechler, Ph.D., was ... Incorporated. From 1988 to 1994, Dr. Buechler was ... Dr. Buechler was a senior research scientist for ...
(Date:12/16/2009)... Germany, December 16 Eppendorf has ... and Verigene(R) SP systems for,infringement of European ... "Method for the,identification and/or the quantification of ... and all imports of the respective products ... authorities are required to confiscate any,violating products. ...
(Date:12/15/2009)... -- Epeius Biotechnologies Corporation, an emerging leader in ... validation of the cutting-edge science behind its lead ... the world rediscovered the Cyclin G1 gene ... pathogenesis and disease progression, and thus a prime ... NIH National Cancer Institute investigating the role of ...
Breaking Biology Technology:Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 2Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 3Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 4Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 5Sequenom Appoints Two New Board Members 2Sequenom Appoints Two New Board Members 3Eppendorf Successfully Initiates Import ban Against Nanosphere, Inc. for the Countries of the European Union 2Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3
... in the field of electrospinning for applications primarily within ... Zeus, Inc. announces a new technology platform in ... fibers with thicknesses ranging from the nano to microscale. ... from solutions, pastes, and bioabsorbables. The result is a ...
... Probably not, but a hamster wearing a power-generating ... a new and renewable source of electricity. , And ... have also generated electrical current from a tapping finger ... and other handhelds one step closer to powering them ...
... On February 10, 2009, NeoStem, Inc. (NYSE Alternext ... Alternext US (the "Alternext") indicating that the Company is ... Company Guide (the "Guide"), which requires a listed company ... 3, 2008, the Company had announced that it planned ...
Other Biology Technology:Electrospinning: Emerging New Technology at Zeus 2Nanogenerators produce electricity from running rodents and tapping fingers 2Nanogenerators produce electricity from running rodents and tapping fingers 3NeoStem Receives Notice of Noncompliance from NYSE Alternext US 2
(Date:12/16/2009)... molecules form an intricate network of interactions. Today,s ... individual molecular reactions outside the cells. Since molecular ... the laboratory, scientists suspect that the kinetics of ... external probes. We expected the cellular reaction speed ... Braun. "However, our novel optical approach showed that ...
(Date:12/16/2009)... A University of Maryland School of Medicine researcher will ... nation,s most prominent scientists in the field of stem ... and Preventive Medicine, was chosen by the National Heart, ... of this consortium of national experts, which will be ... center will be funded by a $30 million grant ...
(Date:12/16/2009)... Dec. 3 BIO-key International, Inc. ... wireless public safety and finger-based biometric identification ... shareholders at a Special Shareholder Meeting held ... Law Enforcement Division to Interact911 Mobile Systems ... cast in favor and 1.2% were opposed. ...
Breaking Biology News(10 mins):Looking for the heartbeat of cellular networks 2University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 2University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 3BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3Genomic Health to Present at Piper Jaffray Health Care Conference 14955 1Genomic Health to Present at Piper Jaffray Health Care Conference 14955 2Visage Imaging Introduces Visage 28R 29 7 for Windows and Mac OS X 6500 1Visage Imaging Introduces Visage 28R 29 7 for Windows and Mac OS X 6500 2Keryx Biopharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 6495 1Keryx Biopharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 6495 2
... Universitys Molecular Biosensor and Imaging Center have developed ... a key component of novel molecular biosensor technology ... can be used to monitor biological activities of ... in real time, are described in the February ...
... Southern Ocean, large quantities of surface-drifting plankton algae are able ... waters, which can affect the global carbon dioxide cycle. This ... has just drawn to a close in Cape Town on ... Institute, part of the Helmholtz Association. On February 5, an ...
... expedition of the Integrated Ocean Drilling Programs Nankai ... off the Kii Peninsula today. The expedition science ... on Dec. 19, 2007, aboard the drilling vessel ... physical characteristics of the Nankai Trough fault zone. ...
Other Biology News:Carnegie Mellon scientists develop fluorescent proteins for live cell imaging, biosensor design 2Carnegie Mellon scientists develop fluorescent proteins for live cell imaging, biosensor design 3Antarctic expedition provides new insights into the role of the Southern Ocean for global climate 2Antarctic expedition provides new insights into the role of the Southern Ocean for global climate 3Antarctic expedition provides new insights into the role of the Southern Ocean for global climate 4Scientists obtain core samples from subsea fault system off Japan 2
Request Info...
Laminin beta-1/gamma-1 (612C10)...
HSV 1 IgM...
100 ug affinity purified rabbit anti-JIP-1 polyclonal antibody. Reacts with mouse and rat. Perform well in Western blotting. Other applications have not been tested. Storage Temperature: -20C Shi...
Biology Products: